Soluble membrane-type 3 matrix metalloproteinase causes changes in gene expression and increased gelatinase activity during Xenopus laevis development

International Journal of Developmental Biology

Volumn 51, Issue 5, 2007, Pages 388-395

  Walsh, Logan A ^a   Cooper, Colin A ^a   Damjanovski, Sashko ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Matrix metalloproteinase; MT3 MMP; Xenopus laevis

Indexed keywords

GELATINASE A; STROMELYSIN; GELATINASE; MATRIX METALLOPROTEINASE 16; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYO DEATH; ENZYME ACTIVITY; GASTRULATION; GENE EXPRESSION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; XENOPUS LAEVIS; ANIMAL; ANIMAL EMBRYO; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENETIC MARKER; GENETICS; METABOLISM; PRENATAL DEVELOPMENT; SOLUBILITY;

XENOPUS LAEVIS;

ANIMALS; EMBRYO, NONMAMMALIAN; ENZYME ACTIVATION; GELATINASES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENETIC MARKERS; MATRIX METALLOPROTEINASE 16; PHENOTYPE; RNA, MESSENGER; SOLUBILITY; XENOPUS LAEVIS;

EID: 34548281134     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.0622531w     Document Type: Article

References (31)

1. CAO, J., KOZAREKAR, P., PAVLAKI, M., CHIARELLI, C., BAHOU, W.F. and ZUCKER, S. (2004). Distinct roles for the catalytic and hemopexin domains of membrane type 1-matrix metalloproteinase in substrate degradation and cell migration. J Biol Chem 279: 14129-39.
2. COUSSENS, L.M., TINKLE, C.L., HANAHAN, D. and WERB, Z. (2000). Mmp-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103: 481-90.
3. DAMJANOVSKI, S., AMANO, T., Ll, Q., PEI, D. and SHI, Y.B. (2001). Overexpression of matrix metalloproteinases leads to lethality in transgenic Xenopus laevis: Implications for tissue-dependent functions of matrix metalloproteinases during late embryonic development. Dev Dyn 221: 37-47.
4. DE ROBERTIS, E.M., KIM, S., LEYNS, L., PICCOLO, S., BACHILLER, D., AGIUS, E., BELO, J.A., YAMAMOTO, A., HAINSKI-BROUSSEAU, A., BRIZUELA, B. et al. (1997). Patterning by genes expressed in spemann's organizer. Cold Spring Harb Symp Quant Biol 62: 169-75.
5. DJE, M.K., MAZABRAUD, A., VIEL, A., LE MAIRE, M., DENIS, H., CRAWFORD, E. and BROWN, D.D. (1990). Three genes under different developmental control encode elongation factor 1-alpha in Xenopus laevis. Nucleic Acids Res 18: 3489-93.
6. FREIJE, J.M., BALBIN, M., PENDAS, A.M., SANCHEZ, L.M., PUENTE, X.S. and LOPEZ-OTIN, C. (2003). Matrix metalloproteinases and tumor progression. Adv Exp Med Biol 532: 91-107.
7. HAMMOUD, L., WALSH, L.A. and DAMJANOVSKI, S. (2006). Cloning and developmental characterization of Xenopus laevis membrane type-3 matrix metalloproteinase (mt3-mmp). Biochem Cell Biol 84: 167-77.
8. HERNANDEZ-BARRANTES, S., BERNARDO, M., TOTH, M. and FRIDMAN, R. (2002). Regulation of membrane type-matrix metalloproteinases. Semin Cancer Biol 12: 131-8.
9. HOIKKALA, S., PAAKKO, P., SOINI, Y., MAKITARO, R., KINNULA, V. and TURPEENNIEMI-HUJANEN, T. (2006). Tissue mmp-2/timp-2-complex are better prognostic factors than serum mmp-2, mmp-9 or timp-1 in stage i-iii lung carcinoma. Cancer Lett 236: 125-32.
10. HOLMBECK, K., BIANCO, P., CATERINA, J., YAMADA, S., KROMER, M., KUZNETSOV, S.A., MANKANI, M., ROBEY, P.G., POOLE, A.R., PIDOUX, I. et al. (1999). Mt1-mmp-deficient mice develop dwarfism, osteopenia, arthritis and connective tissue disease due to inadequate collagen turnover. Cell 99: 81-92.
11. JIANG, A. and PEI, D. (2003). Distinct roles of catalytic and pexin-like domains in membrane-type matrix metalloproteinase (mmp)-mediated pro-mmp-2 activation and collagenolysis. J Biol Chem 278: 38765-71.
12. KANG, T., NAGASE, H. and PEI, D. (2002). Activation of membrane-type matrix metalloproteinase 3 zymogen by the proprotein convertase furin in the transgolgi network. Cancer Res 62: 675-81.
13. KANG, T., YI, J., YANG, W., WANG, X., JIANG, A. and PEI, D. (2000). Functional characterization of mt3-mmp in transfected mdck cells: Progelatinase a activation and tubulogenesis in 3-d collagen lattice. Faseb J 14: 2559-68.
14. KLEIN, S.A., ANDERSON, G.L., KENNEDY, A.B. and BOND, S.J. (2002). The effects of a broad-spectrum matrix metalloproteinase inhibitor on characteristics of wound healing. J Invest Surg 15: 199-207.
15. MONTERO, J.A. and HEISENBERG, C.P. (2004). Gastrulation dynamics: Cells move into focus. Trends Cell Biol 14: 620-7.
16. NIEUWKOOP, P.D. and FABER, J. (1956). Normal table of Xenopus laevis (Daudin); a systematical and chronological survey of the development from the fertilized egg till the end of metamorphosis. Amsterdam, North-Holland Pub.
17. OSENKOWSKI, P., TOTH, M. and FRIDMAN, R. (2004). Processing, shedding and endocytosis of membrane type 1-matrix metalloproteinase (mt1-mmp). J Cell Physiol 200: 2-10.
18. PICKARD, B. and DAMJANOVSKI, S. (2004). Overexpression of the tissue inhibitor of metalloproteinase-3 during Xenopus embryogenesis affects head and axial tissue formation. Cell Res 14: 389-99.
19. SASAI, Y., LU, B., PICCOLO, S. and DE ROBERTIS, E.M. (1996). Endoderm induction by the organizer-secreted factors chordin and noggin in Xenopus animal caps. Embo J 15: 4547-55.
20. SASAI, Y., LU, B., STEINBEISSER, H., GEISSERT, D., GONT, L.K. and DE ROBERTIS, E.M. (1994). Xenopus chordin: A novel dorsalizing factor activated by organizer-specific homeobox genes. Cell 79: 779-90.
21. SHIMADA, T., NAKAMURA, H., OHUCHI, E., FUJII, Y., MURAKAMI, Y., SATO, H., SEIKI, M. and OKADA, Y. (1999). Characterization of a truncated recombinant form of human membrane type 3 matrix metalloproteinase. Eur J Biochem 262: 907-14.
22. SOMERVILLE, R.P., OBLANDER, S.A. and APTE, S.S. (2003). Matrix metalloproteinases: Old dogs with new tricks. Genome Biol 4: 216.
23. SOMIARI, S.B., SHRIVER, C.D., HECKMAN, C., OLSEN, C., HU, H., JORDAN, R., ARCIERO, C., RUSSELL, S., GARGUILO, G., HOOKE, J. et al. (2006). Plasma concentration and activity of matrix metalloproteinase 2 and 9 in patients with breast disease, breast cancer and at risk of developing breast cancer. Cancer Lett 233: 98-107.
24. SOUNNI, N.E. and NOEL, A. (2005). Membrane type-matrix metalloproteinases and tumor progression. Biochimie 87: 329-42.
25. STAMENKOVIC, I. (2003). Extracellular matrix remodelling: The role of matrix metalloproteinases. J Pathol 200: 448-64.
26. VANSAUN, M.N. and MATRISIAN, L.M. (2006). Matrix metalloproteinases and cellular motility in development and disease. Birth Defects Res C Embryo Today 78: 69-79.
27. WANG, P., NIE, J. and PEI, D. (2004a). The hemopexin domain of membrane-type matrix metalloproteinase-1 (mt1-mmp) is not required for its activation of prommp2 on cell surface but is essential for mt1-mmp-mediated invasion in three-dimensional type i collagen. J Biol Chem 279: 51148-55.
28. WANG, X., MA, D., KESKI-OJA, J. and PEI, D. (2004b). Co-recycling of mt1-mmp and mt3-mmp through the trans-golgi network. Identification of dkv582 as a recycling signal. J Biol Chem 279: 9331-6.
29. WISEMAN, B.S., STERNLICHT, M.D., LUND, L.R., ALEXANDER, C.M., MOTT, J., BISSELL, M.J., SOLOWAY, P., ITOHARA, S. and WERB, Z. (2003). Site-specific inductive and inhibitory activities of mmp-2 and mmp-3 orchestrate mammary gland branching morphogenesis. J Cell Biol 162: 1123-33.
30. WU, M. and GERHART, J. (1991 (Raising Xenopus in the laboratory. Methods Cell Biol 36: 3-18.
31. ZHAO, H., BERNARDO, M.M., OSENKOWSKI, P., SOHAIL, A., PEI, D., NAGASE, H., KASHIWAGI, M., SOLOWAY, P.D., DECLERCK, Y.A. and FRIDMAN, R. (2004). Differential inhibition of membrane type 3 (mt3)-matrix metalloproteinase (mmp) and mt1-mmp by tissue inhibitor of metalloproteinase (timp)-2 and timp-3 rgulates pro-mmp-2 activation. J Biol Chem 279: 8592-601.